{"id": "1379513363730956292", "creation": 1617736590.0, "user_id": "2826292747", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 5, "reply_count": 0, "like_count": 9, "quote_count": 0}}, "text": "Description of mRNA-1273 (Moderna) #vaccine-elicited binding and neutralizing antibodies in 33 healthy adult participants in an ongoing phase 1 trial, stratified according to age, at 180 days after the second dose of 100 \u03bcg (day 209) https://t.co/pVAJPhhLGM via @NEJM #COVID19 https://t.co/kqRNEpN7LA", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}